GC
GMAB icon

Guggenheim Capital’s Genmab GMAB Stock Holding History

Guggenheim Capital’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-6,563
Closed -$231K – 1903
2023
Q3 		$231K Sell
6,563
-98
-1% -$3.73K ﹤0.01% 1717
2023
Q2 		$253K Sell
6,661
-102
-2% -$4.07K ﹤0.01% 1711
2023
Q1 		$255K Sell
6,763
-77
-1% -$2.96K ﹤0.01% 1726
2022
Q4 		$290K Sell
6,840
-38,799
-85% -$1.6M ﹤0.01% 1679
2022
Q3 		$1.47M Sell
45,639
-2,360
-5% -$82.9K 0.01% 972
2022
Q2 		$1.56M Buy
47,999
+3,292
+7% +$107K 0.01% 1010
2022
Q1 		$1.62M Buy
44,707
+1,801
+4% +$61.8K 0.01% 1124
2021
Q4 		$1.7M Sell
42,906
-149
-0.3% -$6.21K 0.01% 1134
2021
Q3 		$1.88M Sell
43,055
-1,030
-2% -$46.2K 0.01% 1083
2021
Q2 		$1.8M Buy
44,085
+2,678
+6% +$103K 0.01% 1150
2021
Q1 		$1.36M Buy
41,407
+13,662
+49% +$514K 0.01% 1234
2020
Q4 		$1.13M Buy
+27,745
New +$1.04M 0.01% 1275

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Guggenheim Capital's GMAB Position: Q4 2023 in Review

Guggenheim Capital sold out of Genmab (GMAB) in Q4 2023, closing a stake of 6,563 shares — an estimated $231K sold.

Guggenheim Capital first reported a position in GMAB in Q4 2020 and held it in 12 quarters. The position peaked at $1.88M in Q3 2021. 225 funds tracked by Wall St. Rank hold GMAB as of Q4 2023.

  • Guggenheim Capital reported no remaining Genmab position as of Q4 2023 after selling out during the quarter.
  • Guggenheim Capital sold 6,563 Genmab shares in Q4 2023, an estimated $231K.
  • Guggenheim Capital first reported a position in Genmab in Q4 2020 and held it in 12 quarters.
  • Guggenheim Capital's Genmab position peaked at $1.88M in Q3 2021.
  • 225 funds tracked by Wall St. Rank held Genmab as of Q4 2023.

Based on Guggenheim Capital's 13F filing for Q4 2023, filed 14 Feb 2024.